Related Experiment Video
Updated: May 26, 2026

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care
Stefano Nistri1, Pompilio Faggiano, Iacopo Olivotto
1CMSR Veneto Medica, Altavilla Vicentina, Italy. snistr@tin.it
Insights
Rapid hemodynamic progression of aortic stenosis (AS) in primary care patients independently predicts mortality and aortic valve replacement (AVR). This progression is common in elderly, asymptomatic individuals, highlighting the need for monitoring.
Area of Science:
- Cardiology
- Echocardiography
- Public Health
Background:
- Aortic stenosis (AS) progression is often studied in specialized centers.
- Understanding AS progression in primary care is crucial for early intervention.
Purpose of the Study:
- To investigate the prognostic significance of rapid hemodynamic progression of AS in a nonreferral setting.
- To identify predictors of mortality and aortic valve replacement (AVR) in asymptomatic AS patients.
Main Methods:
- Retrospective review of clinical and echocardiographic data from 153 asymptomatic AS patients.
- Paired echocardiograms analyzed for peak aortic velocity (Vmax) progression over a mean of 2.9 years.
- Progression classified as slow (<0.3 m/s/yr) or fast (>0.3 m/s/yr).
- End points: all-cause mortality and composite of mortality/AVR.
Main Results:
- 49% of patients exhibited fast hemodynamic progression.
- Fast progression independently predicted mortality (HR 13.352) and the composite end point (HR 12.307).
- Initial Vmax also predicted the composite end point (HR 2.684).
- Mortality rate exceeded the general population (p <0.001).
Conclusions:
- Asymptomatic AS patients in primary care are often elderly and show frequent rapid hemodynamic progression.
- Rapid Vmax increase is a significant independent predictor of both mortality and AVR.
- These findings underscore the importance of monitoring AS progression in primary care settings.
Abstract:
The prognostic relevance of a rapid rate of hemodynamic progression of aortic stenosis (AS) has been predominantly investigated in tertiary centers. We reviewed the clinical and echocardiographic data from 153 asymptomatic patients with AS (age 77 ± 9 years; 65% men), with normal left ventricular function and paired echocardiograms ≥4 months apart (mean 2.9 ± 2.1 years), evaluated in a nonreferral echocardiographic laboratory. The severity of AS was graded by the peak aortic velocity (Vmax) and progression was classified as slow or fast according to a cutoff value of 0.3 m/s increase annually. The end points were all-cause mortality and a composite of all-cause mortality and aortic valve replacement (AVR). At baseline, 135 patients (88%) had mild-to-moderate and 18 (12%) severe AS. Of the 153 patients, 49 (32%) showed fast progression (0.61 ± 0.32 m/s/yr) and 104 (68%) had slow progression (0.10 ± 0.16 m/s/yr). Among the 144 patients (94%) with clinical follow-up data, 40 died and 48 underwent AVR. The mortality rate was greater than that of the general population (p <0.001). On multivariate analysis, the independent predictors of mortality were the yearly change in Vmax (hazard ratio [HR] 13.352 per m/s increase, 95% confidence interval [CI] 5.136 to 34.713, p <0.001) and age (HR 1.122 per year, 95% CI 1.0728 to 1.735, p <0.001). The predictors of the composite end point of death and AVR were the yearly change in Vmax (HR 12.307, 95% CI 6.024 to 25.140, p <0.001) and Vmax on the initial echocardiogram (HR 2.684, 95% CI 1.921 to 3.750, p <0.001). In conclusion, primary care patients with asymptomatic AS are usually elderly and frequently develop rapid hemodynamic progression, which independently predicts, not only AVR, but also overall mortality.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests